Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 36 publications
Cost-effectiveness of perioperative pembrolizumab plus enfortumab vedotin for cisplatin-ineligible or cisplatin-declining patients with muscle-invasive bladder cancer in the United States.
Journal: Journal of medical economics
Published: August 18, 2026
Perioperative Enfortumab Vedotin and Pembrolizumab in Bladder Cancer.
Journal: The New England journal of medicine
Published: February 18, 2026
Perioperative Treatment Patterns for Muscle-Invasive Bladder Cancer Patients Undergoing Radical Cystectomy in the Adjuvant Immunotherapy Era: A Retrospective Analysis of US Community Oncology Practice.
Journal: Oncology and therapy
Published: January 19, 2026
Real-world treatment patterns, recurrence, and overall survival of patients with muscle-invasive bladder cancer undergoing radical cystectomy in U.S. oncology practice.
Journal: Urologic oncology
Published: September 16, 2025
Characteristics, Treatment Patterns, and Outcomes of Patients with Muscle-Invasive Bladder Cancer Undergoing Radical Cystectomy: A Retrospective Analysis of Health Insurance Claims Data in Germany.
Journal: Oncology and therapy
Published: September 13, 2025
TROPHY-U-01 Cohort 2: A Phase II Study of Sacituzumab Govitecan in Cisplatin-Ineligible Patients With Metastatic Urothelial Cancer Progressing After Previous Checkpoint Inhibitor Therapy.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: August 26, 2024
Real-world Uptake of Enfortumab Vedotin plus Pembrolizumab after US Food and Drug Administration Approval Among Patients with Advanced Urothelial Cancer.
Journal: European urology
Published: July 18, 2024
Perioperative Immune Checkpoint Blockade for Muscle-Invasive and Metastatic Bladder Cancer.
Journal: Journal of cancer immunology
Published: May 24, 2024
Sacituzumab Govitecan in Combination With Pembrolizumab for Patients With Metastatic Urothelial Cancer That Progressed After Platinum-Based Chemotherapy: TROPHY-U-01 Cohort 3.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: January 23, 2024
Patient-Reported Outcomes in Patients With Advanced Urothelial Cancer Who Are Ineligible for Cisplatin and Treated With First-Line Enfortumab Vedotin Alone or With Pembrolizumab.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: January 12, 2024
Cost-Effectiveness Analysis for Therapy Sequence in Advanced Cancer: A Microsimulation Approach with Application to Metastatic Prostate Cancer.
Journal: Medical decision making : an international journal of the Society for Medical Decision Making
Published: October 09, 2023
Last Updated: 09/26/2026